相关实验视频
Updated: Jan 12, 2026

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
39.6K
辩证行为疗法与血清素再吸收抑制剂对边界人格障碍自杀行为的治疗:随机对照试验
Beth S Brodsky1,2, Hanga Galfalvy2,3, J John Mann1,2
1Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York.
The American journal of psychiatry
|November 5, 2025
概括
辩证行为疗法 (DBT) 在边界人格障碍患者中显著降低了与自杀相关的事件 (SREs) 和非自杀性自伤 (NSSI),比临床管理 (SSRI/M) 的选择性血清素再吸收抑制剂更有效. 结果在12个月后是可比的.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
背景情况:
- 边界性人格障碍 (BPD) 是一种复杂的心理健康状况,通常与高比例的自杀相关事件 (SREs) 和非自杀性自伤 (NSSI) 相关.
- 有效的BPD治疗策略对于改善患者的治疗结果和减少医疗负担至关重要.
研究的目的:
- 为了比较6个月的辩证行为疗法 (DBT) 与6个月的选择性血清素再吸收抑制剂与临床管理 (SSRI / M) 在减少BSE,自杀企图和BSI的人群中的有效性.
- 评估与BPD患者相关的临床结果,包括抑郁症严重程度和自杀念头.
主要方法:
- 一项随机对照试验,涉及84名被诊断患有BPD和近期SRE或NSSI史的个人.
- 参与者被分配给DBT或SSRI/M治疗6个月.
- 统计分析包括Poisson模型,零膨胀的Poisson模型,生存分析和混合效应回归.
主要成果:
- 与SSRI/M组相比,DBT组在6个月的治疗阶段显著减少了SRE和NSSI行为.
- 生存分析显示,在DBT组中,经历任何SRE的风险明显较低.
- 虽然抑郁症和自杀念头的严重程度在两组中都相对下降,但SSRI/M组在治疗后的重大抑郁症发病率较低.
结论:
- 六个月的DBT在减少BSD患者的SRE和NSSI行为方面表现出比SSRI/M更高的疗效.
- 尽管最初存在差异,但在12个月的随访期间,DBT和SSRI/M之间的治疗结果变得可比.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
791
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
791
Rational Emotive Behavior Therapy
340
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
340
Borderline Personality Disorder
511
Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
Genetic and Environmental Contributions
Borderline Personality...
511
Electroconvulsive Therapy
841
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
841
Behavior Therapy
597
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
597
Drug Therapy
237
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
237

